Impact of COVID‐19 pandemic on ST‐elevation myocardial infarction in a non‐COVID‐19 epicenter. Issue 2 (1st June 2020)

• Record Type: Journal Article
• Authors: Hammad, Tarek A.; Parikh, Melanie; Tashtish, Nour; Lowry, Cynthia M.; Gorbey, Diane; Forouzandeh, Farshad; Filby, Steven J.; Wolf, William M.; Costa, Marco A.; Simon, Daniel I.; Shishehbor, Mehdi H.
• Is Part Of: Catheterization and cardiovascular interventions. Volume 97:Issue 2(2021)
• Page Start: 208
• Page End: 214
• Publication Date: 2020-06-01
• Subjects: coronavirus -- delayed presentation -- door‐to‐balloon -- length of stay -- troponin; Heart -- Diseases -- Diagnosis -- Periodicals; Cardiac catheterization -- Periodicals; 616.1207572
• DOI: 10.1002/ccd.28997
• Languages: English
• ISSNs: 1522-1946

Abstract

Abstract: Objectives: We sought to study the impact of COVID‐19 pandemic on the presentation delay, severity, patterns of care, and reasons for delay among patients with ST‐elevation myocardial infarction (STEMI) in a non‐hot‐spot region. Background: COVID‐19 pandemic has significantly reduced the activations for STEMI in epicenters like Spain. Methods: From January 1, 2020, to April 15, 2020, 143 STEMIs were identified across our integrated 18‐hospital system. Pre‐ and post‐COVID‐19 cohorts were based on March 23rd, 2020, whenstay‐at‐home orders were initiated in Ohio. We used presenting heart rate, blood pressure, troponin, new Q‐wave, and left ventricle ejection fraction (LVEF) to assess severity. Duration of intensive care unit stay, total length of stay, door‐to‐balloon (D2B) time, and radial versus femoral access were used to assess patterns of care. Results: Post‐COVID‐19 presentation was associated with a lower admission LVEF (45 vs. 50%, p = .015), new Q‐wave, and higher initial troponin; however, these did not reach statistical significance. Among post‐COVID‐19 patients, those with >12‐hr delay in presentation 31(%) had a longer average D2B time (88 vs. 53 min, p = .033) and higher peak troponin (58 vs. 8.5 ng/ml, p = .03). Of these, 27% avoided the hospital due to fear of COVID‐19, 18% believed symptoms were COVID‐19 related, and 9% did not want to burden the hospital during the pandemic. Conclusions: COVID‐19 has remarkably affected STEMI presentation and care. Patients' fear and confusion about symptoms are integral parts of this emerging public health crisis.